Impact of Beta Blockers on TAVI (BETA-TAVI)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 348 participants.
Also called NCT05721170
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 348 participants
- Registry
-
NCT05721170
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Cyprus, Greece
- Registry status
- Recruiting
Technical summary
Registry record NCT05721170. Randomized; no masking; primary purpose treatment. Start 2024-06-01 (actual); primary completion 2028-01-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Impact of Beta Blockers on TAVI (BETA-TAVI)
- Acronym
- BETA-TAVI
- Condition
- Aortic Valve Stenosis
- Intervention (Drug)
- Beta blocker
- Lead sponsor
- National and Kapodistrian University of Athens
- Collaborator
- Evangelismos Hospital
- Collaborator
- Interbalkan Medical Center, Thessaloniki, Greece
Record details
- Record id
cardio:ct-nct05721170- Content hash
e2f19a3ed529dace4453b060217bffeba353ae5820cb24ae4dd097c79d5e6f3f